[go: up one dir, main page]

DE60120440D1 - Zellkernlokalisierendes protein für beta-catenin - Google Patents

Zellkernlokalisierendes protein für beta-catenin

Info

Publication number
DE60120440D1
DE60120440D1 DE60120440T DE60120440T DE60120440D1 DE 60120440 D1 DE60120440 D1 DE 60120440D1 DE 60120440 T DE60120440 T DE 60120440T DE 60120440 T DE60120440 T DE 60120440T DE 60120440 D1 DE60120440 D1 DE 60120440D1
Authority
DE
Germany
Prior art keywords
protein
beta
catenine
corrosive
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60120440T
Other languages
English (en)
Other versions
DE60120440T2 (de
Inventor
Tetsu Akiyama
Shungo Adachi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of DE60120440D1 publication Critical patent/DE60120440D1/de
Application granted granted Critical
Publication of DE60120440T2 publication Critical patent/DE60120440T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60120440T 2000-09-22 2001-09-19 Zellkernlokalisierendes protein für beta-catenin Expired - Lifetime DE60120440T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000287876 2000-09-22
JP2000287876 2000-09-22
PCT/JP2001/008140 WO2002024738A1 (en) 2000-09-22 2001-09-19 β-CATENIN NUCLEAR LOCALIZED PROTEIN

Publications (2)

Publication Number Publication Date
DE60120440D1 true DE60120440D1 (de) 2006-07-20
DE60120440T2 DE60120440T2 (de) 2007-01-04

Family

ID=18771553

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60120440T Expired - Lifetime DE60120440T2 (de) 2000-09-22 2001-09-19 Zellkernlokalisierendes protein für beta-catenin

Country Status (10)

Country Link
US (1) US7358348B2 (de)
EP (1) EP1323732B9 (de)
JP (1) JPWO2002024738A1 (de)
KR (1) KR20030045083A (de)
AT (1) ATE328899T1 (de)
AU (1) AU2001290242A1 (de)
CA (1) CA2423108A1 (de)
DE (1) DE60120440T2 (de)
ES (1) ES2264450T3 (de)
WO (1) WO2002024738A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7049290B2 (en) 2000-07-28 2006-05-23 Universität Zürich Essential downstream component of the wingless signaling pathway and therapeutic and diagnostic applications based thereon
KR100508815B1 (ko) * 2003-01-08 2005-08-19 국립암센터 β-카테닌 올리고뉴클레오티드 마이크로칩 및 이를이용하여 β-카테닌 유전자의 돌연변이를 검사하는 방법
WO2007022346A2 (en) * 2005-08-15 2007-02-22 The Regents Of The University Of California Cellular function underlying bone micro-structure characteristic of type 2 diabetes
KR101718507B1 (ko) * 2012-07-02 2017-03-22 사회복지법인 삼성생명공익재단 암 치료제 스크리닝 방법
EP3883588A4 (de) 2018-11-21 2022-10-19 Endomet Biosciences, Inc. Zusammensetzungen und verfahren zur behandlung von endometriose
KR102084953B1 (ko) 2019-09-18 2020-05-26 문동석 배기가스 정화용 집진 장치
KR102454946B1 (ko) 2021-09-30 2022-10-17 문동석 배기 가스 미세먼지 집진장치
CN115124619B (zh) * 2022-06-24 2023-05-05 广东齐美医药生物科技集团有限公司 临床血液免疫细胞的制备方法及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658784A (en) * 1994-04-14 1997-08-19 Dana-Farber Cancer Institute, Inc. Nucleic acid encoding transcription factor p300 and uses of p300
EP1165784A2 (de) 1999-03-31 2002-01-02 Curagen Corporation Nukleinsäuren mit offener leserahmen, die polypeptiden kodieren; "orfx"
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
WO2001092523A2 (en) * 2000-05-30 2001-12-06 Curagen Corporation Human polynucleotides and polypeptides encoded thereby
US7049290B2 (en) * 2000-07-28 2006-05-23 Universität Zürich Essential downstream component of the wingless signaling pathway and therapeutic and diagnostic applications based thereon

Also Published As

Publication number Publication date
ATE328899T1 (de) 2006-06-15
EP1323732A1 (de) 2003-07-02
JPWO2002024738A1 (ja) 2004-01-29
EP1323732B9 (de) 2008-02-27
KR20030045083A (ko) 2003-06-09
CA2423108A1 (en) 2003-03-19
AU2001290242A1 (en) 2002-04-02
WO2002024738A1 (en) 2002-03-28
DE60120440T2 (de) 2007-01-04
EP1323732B1 (de) 2006-06-07
US7358348B2 (en) 2008-04-15
EP1323732A4 (de) 2004-08-04
ES2264450T3 (es) 2007-01-01
US20040073001A1 (en) 2004-04-15

Similar Documents

Publication Publication Date Title
MXPA04000062A (es) Miembros de drenaje extensibles para conectar a tierra la proteccion por interferencia electromagnetica/interferencia por radiofrecuencia.
CR10022A (es) Agentes que se enlazan con un objetivo en el tejido pulmonar para el tratamiento de enfermedades respiratorias
AR030236A1 (es) Moléculas similares a il-17 y usos de las mismas
EA200000759A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
IS6491A (is) Pteridínefnasambönd til meðhöndlunar á sóríasis
BR0111125A (pt) Moléculas de ácido nucléico de nrg-2, polipeptìdeos, e métodos diagnóstico e terapêuticos
ES2168737T3 (es) Inhibidores de la oxido nitrico sintasa.
BR0316502A (pt) Compostos quìmicos
ATE408601T1 (de) Fredericamycin-derivate
BR0112644A (pt) Método de identificar marcadores de câncer e usos destes no diagnóstico do câncer
BRPI0409359A (pt) análogos quiméricos de somatostatina-dopamina
DE60120440D1 (de) Zellkernlokalisierendes protein für beta-catenin
CY1113525T1 (el) Θεραπεια στοχευσης καθεψινης s
WO2004025303A3 (en) Isoprostanes as markers of psychological stress in humans
IL212653A0 (en) Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof
BR0312863A (pt) Derivados de aldeìdo de polietileno glicol
ATE234858T1 (de) Isolierte und verkürzte nukleinsäuremoleküle kodierend für gage-tumorabstossungsantigen
DK1353948T3 (da) Oplöselige biologiske analoge til bata-amyloidpeptid
WO2003001182A3 (en) Homocysteinylated transthyretin
ATE277352T1 (de) Einetenascin-c isoform als marker für neoplasmen
BR0009573A (pt) Composições e métodos para o tratamento e diagnose do câncer de mama
PL365279A1 (en) Biotin-derivates and their conjugates with chelating agents
ATE282697T1 (de) Vektorkonstrukte zur gentherapeutisch vermittelten radionuklid-therapie entdifferenzierter und medullärer schilddrüsen- karzinome sowie nicht-thyreoidaler tumore und ihrer metastasen
BR0308180A (pt) protéinas de superfìcie de leptospira
DE60144027D1 (de) 5t4 rna in plasma und serum als marker für neoplastische erkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: KYOWA HAKKO KIRIN CO., LTD., TOKYO, JP